Cicalini, S.; Lanini, S.; Gagliardini, R.; Bellagamba, R.; Vergori, A.; Mastrorosa, I.; Mazzotta, V.; Esvan, R.; Plazzi, M.M.; Ottou, S.;
et al. Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study. Pharmaceuticals 2024, 17, 1706.
https://doi.org/10.3390/ph17121706
AMA Style
Cicalini S, Lanini S, Gagliardini R, Bellagamba R, Vergori A, Mastrorosa I, Mazzotta V, Esvan R, Plazzi MM, Ottou S,
et al. Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study. Pharmaceuticals. 2024; 17(12):1706.
https://doi.org/10.3390/ph17121706
Chicago/Turabian Style
Cicalini, Stefania, Simone Lanini, Roberta Gagliardini, Rita Bellagamba, Alessandra Vergori, Ilaria Mastrorosa, Valentina Mazzotta, Rozenn Esvan, Maria Maddalena Plazzi, Sandrine Ottou,
and et al. 2024. "Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study" Pharmaceuticals 17, no. 12: 1706.
https://doi.org/10.3390/ph17121706
APA Style
Cicalini, S., Lanini, S., Gagliardini, R., Bellagamba, R., Vergori, A., Mastrorosa, I., Mazzotta, V., Esvan, R., Plazzi, M. M., Ottou, S., Grilli, E., De Zottis, F., Fusto, M., Paulicelli, J., & Antinori, A.
(2024). Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study. Pharmaceuticals, 17(12), 1706.
https://doi.org/10.3390/ph17121706
